BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10930240)

  • 1. Control of olefin geometry in the bryostatin B-ring through exploitation of a C(2)-symmetry breaking tactic and a Smith-Tietze coupling reaction.
    Hale KJ; Hummersone MG; Bhatia GS
    Org Lett; 2000 Jul; 2(15):2189-92. PubMed ID: 10930240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core.
    Keck GE; Truong AP
    Org Lett; 2005 May; 7(11):2153-6. PubMed ID: 15901157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New, abridged pathway to Masamune's "southern hemisphere" intermediate for the total synthesis of bryostatin 7.
    Hale KJ; Frigerio M; Manaviazar S
    Org Lett; 2003 Feb; 5(4):503-5. PubMed ID: 12583754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of the salicylate enamide macrolide oximidine III: application of relay ring-closing metathesis.
    Wang X; Bowman EJ; Bowman BJ; Porco JA
    Angew Chem Int Ed Engl; 2004 Jul; 43(27):3601-5. PubMed ID: 15293258
    [No Abstract]   [Full Text] [Related]  

  • 5. Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7.
    Manaviazar S; Frigerio M; Bhatia GS; Hummersone MG; Aliev AE; Hale KJ
    Org Lett; 2006 Sep; 8(20):4477-80. PubMed ID: 16986929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective total synthesis of antitumor macrolide (+)-rhizoxin D.
    Jiang Y; Hong J; Burke SD
    Org Lett; 2004 Apr; 6(9):1445-8. PubMed ID: 15101763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A divergent approach to the myriaporones and tedanolide: completion of the carbon skeleton of myriaporone 1.
    Taylor RE; Hearn BR; Ciavarri JP
    Org Lett; 2002 Aug; 4(17):2953-5. PubMed ID: 12182597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.
    Keck GE; Truong AP
    Org Lett; 2005 May; 7(11):2149-52. PubMed ID: 15901156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atom-economic and stereoselective syntheses of the ring a and B subunits of the bryostatins.
    Trost BM; Yang H; Brindle CS; Dong G
    Chemistry; 2011 Aug; 17(35):9777-88. PubMed ID: 21774000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new synthetic approach to the C ring of known as well as novel bryostatin analogues.
    Wender PA; Koehler MF; Sendzik M
    Org Lett; 2003 Nov; 5(24):4549-52. PubMed ID: 14627380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient and stereoselective synthesis of the monomeric counterpart of marinomycin A.
    Amans D; Bellosta V; Cossy J
    Org Lett; 2007 Apr; 9(8):1453-6. PubMed ID: 17355145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total syntheses of bryostatins: synthesis of two ring-expanded bryostatin analogues and the development of a new-generation strategy to access the C7-C27 fragment.
    Trost BM; Yang H; Dong G
    Chemistry; 2011 Aug; 17(35):9789-805. PubMed ID: 21780195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unified approach to the tedanolides: total synthesis of (+)-13-deoxytedanolide.
    Smith AB; Adams CM; Barbosa SA; Degnan AP
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12042-7. PubMed ID: 15163795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The practical synthesis of a novel and highly potent analogue of bryostatin.
    Wender PA; Baryza JL; Bennett CE; Bi FC; Brenner SE; Clarke MO; Horan JC; Kan C; LacĂ´te E; Lippa B; Nell PG; Turner TM
    J Am Chem Soc; 2002 Nov; 124(46):13648-9. PubMed ID: 12431074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric synthesis of the northern half C1-C16 of the bryostatins.
    Vakalopoulos A; Lampe TF; Hoffmann HM
    Org Lett; 2001 Mar; 3(6):929-32. PubMed ID: 11263918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
    Kumar VP; Chandrasekhar S
    Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short synthetic pathway to a fully-functionalized southern hemisphere of the antitumor macrolide bryostatin 1.
    Hale KJ; Frigerio M; Manaviazar S
    Org Lett; 2001 Nov; 3(23):3791-4. PubMed ID: 11700140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective synthesis of both tetrahydropyran rings of the antitumor macrolide, (-)-lasonolide A.
    Ghosh AK; Ren GB
    J Org Chem; 2012 Mar; 77(5):2559-65. PubMed ID: 22324913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis of (-)-zampanolide and questionable existence of (-)-dactylolide as the elusive biosynthetic precursor of (-)-zampanolide in an Okinawan sponge.
    Uenishi J; Iwamoto T; Tanaka J
    Org Lett; 2009 Aug; 11(15):3262-5. PubMed ID: 19586001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemistry and biology of the bryostatin antitumour macrolides.
    Hale KJ; Hummersone MG; Manaviazar S; Frigerio M
    Nat Prod Rep; 2002 Aug; 19(4):413-53. PubMed ID: 12195811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.